Login with Linked

Follow us on

Link Linkedin Youtube

Miebo

Miebo is an eye drop that treats dry eye disease by reducing tear evaporation. It forms a protective layer on the eye to keep it moist and comfortable.

Molecule Details :

  • Molecule Name :

    Perfluorhexyloctane

  • Innovator :

    BAUSCH AND LOMB INC

  • Approval Date :

    18-May-23

  • NCE-1 Date :

    18-May-27

  • NCE Date :

    18-May-28

  • Dosage Form :

    Eye Drops

  • Strength :

    1.338GM/ML

  • Therapeutic Category :

    Ophthalmic

  • Revenue ($M) :

    172

Year-wise Projected Sales ($M) :

  • 2025 :

    NA

  • 2026 :

    NA

  • 2027 :

    NA

  • 2028 :

    NA

  • 2029 :

    NA

  • 2030 :

    NA

  • 2031 :

    NA
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.
Request a Quote

Why Choose Spring Bio Solution?

Supported 1000+ Clinical Trials globally

Provides services across regulatory, legal & clinical research

Unmatched intelligence on batches, expiry, spacing, and historical data from innovators

Integrated CRO Services as part of our offerings

Insights on global pricing for smarter clinical trial supply decisions 


Schedule a Call With Us
Login with Linked

Follow us on

Linkedin Youtube Link

Login NCE Grid

Register NCE Grid

Are you sure want to logout from NCE Grid?

Not Now
Logout
Need your comparator insight?